Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adaptive deep brain stimulation in Parkinson disease: clinical implementation and outlook.

Nature reviews. Neurology·2026

Same author

Who Falls After a Stroke? Evidence From a Prospective Stroke Cohort.

European journal of neurology·2026

Same author

Authors' Comments on "Adaptive Deep Brain Stimulation for Parkinson's Disease: Navigating the Roadblocks to Clinical Implementation".

Movement disorders : official journal of the Movement Disorder Society·2026

Same author

Effect of subcutaneous foslevodopa/foscarbidopa therapy on non-motor symptoms in advanced PD patients.

Journal of neurology·2026

Same author

What is new in Freezing of Gait?

Journal of neurology·2026

Same author

Volumetric signatures of basal ganglia-thalamo-cortical and cerebello-thalamo-cortical networks in Parkinson's disease and its motor subtypes.

Frontiers in aging neuroscience·2026

Same journal

Whole-genome sequencing of 197 cases with Parkinson's disease reveals novel pathogenic variants in the Indian population.

NPJ Parkinson's disease·2026

Same journal

Dopamine replacement therapy modulates DDC, prolactin and AOC3 levels in Parkinson's disease.

NPJ Parkinson's disease·2026

Same journal

Sleep and Parkinson's disease: a population-based study from the CHARLS cohort.

NPJ Parkinson's disease·2026

Same journal

Sternum-worn vibrotactile device in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot trial.

NPJ Parkinson's disease·2026

Same journal

Characterizing progressive cortical thinning in multiple system atrophy: a longitudinal MRI study.

NPJ Parkinson's disease·2026

Same journal

CSF turnover dysfunction: a hidden early biomarker in iRBD?

NPJ Parkinson's disease·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 23, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Multiple input algorithm-guided Deep Brain stimulation-programming for Parkinson's disease patients.

Eileen Gülke¹, León Juárez Paz², Heleen Scholtes²

¹Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

NPJ Parkinson'S Disease

|October 30, 2022

Summary

This summary is machine-generated.

A new algorithm-guided-programming (AgP) approach for Deep Brain Stimulation (DBS) in Parkinson's disease (PD) offers similar symptom improvement to standard care but with potentially reduced programming burden. Further research will explore long-term benefits and closed-loop applications.

More Related Videos

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Published on: July 14, 2023

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

Related Experiment Videos

Last Updated: Aug 23, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Published on: July 14, 2023

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

Area of Science:

Neuromodulation
Neuroscience
Biomedical Engineering

Background:

Deep Brain Stimulation (DBS) for Parkinson's disease (PD) has advanced, offering more programming options but increasing complexity.
Optimizing DBS settings is crucial for patient benefit but can be time-consuming and burdensome for clinicians.

Purpose of the Study:

To evaluate the feasibility of a semi-automatic algorithm-guided-programming (AgP) approach for optimizing DBS settings in PD patients.
To compare the acute clinical effectiveness of AgP-guided DBS settings with standard of care (SoC) programming.

Main Methods:

A randomized, crossover, double-blind study in 10 PD subjects with directional DBS systems.
AgP iteratively assessed weighted combinations of sensor and clinician-reported symptom responses to suggested DBS settings.
AgP settings were compared to SoC settings and a no-therapy condition.

Main Results:

Both AgP and SoC DBS settings significantly improved total Unified Parkinson's Disease Rating Scale III scores compared to therapy absence (p=0.002).
AgP tested an average of 37 settings per subject, converging in approximately 1.7 hours.
Despite similar clinical outcomes, AgP and SoC programming resulted in substantially different stimulation settings.

Conclusions:

The algorithm-guided-programming (AgP) approach is a feasible alternative for DBS programming in Parkinson's disease.
AgP demonstrates comparable acute clinical effectiveness to standard programming methods.
This approach represents a significant step towards developing future closed-loop DBS optimization systems.